Graphite Bio Stock Cash Flow From Operations
Graphite Bio fundamentals help investors to digest information that contributes to Graphite Bio's financial success or failures. It also enables traders to predict the movement of Graphite Stock. The fundamental analysis module provides a way to measure Graphite Bio's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Graphite Bio stock.
Graphite |
Graphite Bio Company Cash Flow From Operations Analysis
Graphite Bio's Operating Cash Flow reveals the quality of a company's reported earnings and is calculated by deducting company's income taxes from earnings before interest, taxes, and depreciation (EBITDA). In other words, Operating Cash Flow refers to the amount of cash a firm generates from the sales or products or from rendering services. Operating Cash Flow typically excludes costs associated with long-term investments or investment in marketable securities and is usually used by investors or analysts to check on the quality of a company's earnings.
Current Graphite Bio Cash Flow From Operations | (90.01 M) |
Most of Graphite Bio's fundamental indicators, such as Cash Flow From Operations, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Graphite Bio is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Operating Cash Flow shows the difference between reported income and actual cash flows of the company. If a firm does not have enough cash or cash equivalents to cover its current liabilities, then both investors and management should be concerned about the company having enough liquid resources to meet current and long term debt obligations.
CompetitionIn accordance with the recently published financial statements, Graphite Bio has (90.01 Million) in Cash Flow From Operations. This is 117.07% lower than that of the Biotechnology sector and 243.95% lower than that of the Health Care industry. The cash flow from operations for all United States stocks is 109.27% higher than that of the company.
Graphite Cash Flow From Operations Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Graphite Bio's direct or indirect competition against its Cash Flow From Operations to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Graphite Bio could also be used in its relative valuation, which is a method of valuing Graphite Bio by comparing valuation metrics of similar companies.Graphite Bio is currently under evaluation in cash flow from operations category among its peers.
Graphite Fundamentals
Return On Equity | -0.52 | |||
Return On Asset | -0.18 | |||
Current Valuation | 1.88 M | |||
Shares Outstanding | 58.24 M | |||
Shares Owned By Insiders | 9.17 % | |||
Shares Owned By Institutions | 84.40 % | |||
Number Of Shares Shorted | 704.04 K | |||
Price To Earning | 0.70 X | |||
Price To Book | 1.01 X | |||
EBITDA | (70.7 M) | |||
Net Income | (124.65 M) | |||
Cash And Equivalents | 322.29 M | |||
Cash Per Share | 5.54 X | |||
Total Debt | 362 K | |||
Debt To Equity | 0.02 % | |||
Current Ratio | 27.07 X | |||
Book Value Per Share | 3.17 X | |||
Cash Flow From Operations | (90.01 M) | |||
Short Ratio | 7.93 X | |||
Earnings Per Share | (2.19) X | |||
Price To Earnings To Growth | (0.08) X | |||
Target Price | 7.0 | |||
Beta | 0.2 | |||
Market Capitalization | 189.84 M | |||
Total Asset | 188.46 M | |||
Retained Earnings | (367.05 M) | |||
Working Capital | 183.22 M | |||
Current Asset | 8 K | |||
Current Liabilities | 451 K | |||
Annual Yield | 0.30 % | |||
Net Asset | 188.46 M |
Currently Active Assets on Macroaxis
Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in american community survey. You can also try the Companies Directory module to evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals.
Other Consideration for investing in Graphite Stock
If you are still planning to invest in Graphite Bio check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Graphite Bio's history and understand the potential risks before investing.
Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
Transaction History View history of all your transactions and understand their impact on performance |